These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8767482)

  • 21. Plasma lipoproteins and apolipoproteins.
    Fredrickson DS
    Harvey Lect; 1974; 68():185-237. PubMed ID: 4375673
    [No Abstract]   [Full Text] [Related]  

  • 22. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha.
    Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI
    Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
    Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipolytic enzymes and plasma lipoprotein metabolism.
    Nilsson-Ehle P; Garfinkel AS; Schotz MC
    Annu Rev Biochem; 1980; 49():667-93. PubMed ID: 6996570
    [No Abstract]   [Full Text] [Related]  

  • 25. Modern management of hyperlipidemia.
    Grundy SM
    Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical significance of remnant-lipoprotein].
    Nakamura Y; Miida T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():22-5. PubMed ID: 15658253
    [No Abstract]   [Full Text] [Related]  

  • 27. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins.
    Zilversmit DB
    Circ Res; 1973 Dec; 33(6):633-8. PubMed ID: 4361710
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.
    Beisiegel U
    Curr Opin Lipidol; 1995 Jun; 6(3):117-22. PubMed ID: 7647999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.
    Stanford KI; Wang L; Castagnola J; Song D; Bishop JR; Brown JR; Lawrence R; Bai X; Habuchi H; Tanaka M; Cardoso WV; Kimata K; Esko JD
    J Biol Chem; 2010 Jan; 285(1):286-94. PubMed ID: 19889634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial lipoproteins and progression of coronary atherosclerosis.
    Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A
    Atherosclerosis; 1994 Mar; 106(1):83-97. PubMed ID: 8018110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial hyperlipidemia and remnant lipoproteins.
    Havel RJ
    Curr Opin Lipidol; 1994 Apr; 5(2):102-9. PubMed ID: 8044412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures.
    Sehayek E; Olivecrona T; Bengtsson-Olivecrona G; Vlodavsky I; Levkovitz H; Avner R; Eisenberg S
    Atherosclerosis; 1995 Apr; 114(1):1-8. PubMed ID: 7605368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-ligand interactions in the hepatic uptake of chylomicron remnants studied with genetically manipulated mice.
    Redgrave TG; Mortimer BC; Martins IJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():105-7. PubMed ID: 8767480
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
    Foley EM; Esko JD
    Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipoprotein lipases and lipid homeostasis].
    Clemenzia G; Petroni R
    Recenti Prog Med; 1979 Jan; 66(1):37-57. PubMed ID: 220686
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myocardial infarct. Lipoprotein lipase in the myocardium and the infarct].
    Gaddi A; Descovich GC
    Minerva Cardioangiol; 1980 Jun; 28(6):375-82. PubMed ID: 7242924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.